Pharmaceutical manufacturer for Folic acid

Ami Lifesciences, established in 2006, is one of the fastest growing Active Pharmaceutical Ingredient (API) manufacturing companies in India, meeting unmet patient needs in various therapeutic areas such as Cardiovascular, Anti-Diabetics, CNS, and Respiratory amongst other categories, produced From Manufacturing unit located in Vadodara, Gujarat. We are recognised as a reliable supplier of generic APIs and a trustworthy Contract Development & Manufacturing partner for generic, Big Pharma & innovator pharmaceutical companies worldwide. We are among the leading manufacturers of APIs, intermediates and registered Key Starting Materials offering quality products with highest quality compliance & integrity to over 60+ countries. We believe, unlocking early launch opportunities, being cost competitive by virtue of backward integration and offering complete supply chain assurance is key to enable our customers to succeed & sustain their products through the product life cycle over a period of time.

Maithri Drugs stands as one of the rapidly emerging pharmaceutical firms in India. Maithri's primary emphasis is on active pharmaceutical ingredients (APIs). The corporation is widely acknowledged for its exceptional research & development and ambitious expansion approaches. Our 125+Global DMFs, including 50 in the United States and 22 in the EU within a brief duration, bear witness to our R&D superiority. Maithri's production site is situated in Hyderabad. This site is scrutinized and endorsed by the US FDA. Furthermore, our facility is accredited in accordance with the criteria of DCGI, WHO GMP, and ISO 9001.

Rochem International, Inc. has been a prominent distributor of pharmaceutical, food, nutritional, and animal health ingredients since its establishment in 1994. It procures top-notch ingredients produced in China. With its headquarters in Hauppauge, New York, Rochem operates 16 global offices to meet its clients' requirements. The company's activities adhere to cGMP standards and have undergone audits by the USFDA and various multinational entities. Furthermore, it provides training and conducts audits for its partners to ensure FDA compliance for their technologies and systems.

Zim offers innovative solutions for administering medications, focusing on enhancing patient convenience and compliance. The company utilizes its own advanced technologies, such as modified release and taste masking, to create and produce distinct pharmaceutical products. Their range includes oral solid dosage formulations and pre-formulations (PFI), encompassing tablets, capsules, dry syrups, pellets, granules, and orally disintegrating strips (ODS). Additionally, they provide services for site transfer/variation for sustained release tablets, oral disintegrating tablets, fast disintegrating capsules, and more.

Bayir is a professionally managed corporation involved in the manufacturing and promotion of specific active Pharmaceuticals, Nutraceutical, and Botanical extracts such as Coleus Forskolin, Glucosamine, Garcinia Extract, Chondroitin sulphate, Herbal Extract, and Curcumin. The manufacturing units of the corporation are furnished with modern facilities operated by highly qualified experts and are WHO cGMP certified.

Sri Krishna Pharmaceuticals Ltd (SKPL), established in 1974, started life as a pioneer in the bulk manufacture of acetaminophen (Paracetamol) for the domestic Indian market. Today, the company is a vertically integrated bulk manufacturer of multiple first-line-of-defence APIs, PFIs and finished dosage drugs. Paracetamol is still very important to the company and the company remains one of the largest manufacturers in the world. The role of Indian bulk drug manufacturers in the global pharma supply chain has evolved greatly, with SKPL increasing its presence in the synthesis of bulk APIs, direct compression, intermediate and finished dosage products.

HELM AG, a company based in Hamburg and owned by a family, has a 120-year history in 4 diverse sectors: Pharmaceuticals, Chemicals, Crop Protection, and Crop Nutrition. With a global presence through subsidiaries, sales offices, and partnerships, HELM is recognized as one of the world's leading independent marketing firms for chemicals. At HELM Pharma, our goal is to establish ourselves as the top B2B project and marketing platform, offering a distinctive partnership experience. In the marketing of our products, we deliver a comprehensive range of services for our business associates.

Changzhou Pharmaceutical Factory (CPF) is a subsidiary company of Shanghai Pharma Holdings Co., Ltd., It is headquartered in Changzhou, Jiangsu province, China, Changzhou pharmaceutical Factory has a rich history & Lineage in the pharmaceutical sector. The company was founded in 1949 by (Tan Ruiting) with a registered capital 108 million yuan and the company was restructured as a Changzhou pharmaceutical Factory under the aegis of Shanghai Pharma Group. The Chinese business of Changzhou pharmaceutical factory was full fledged sales & marketing organization,Changzhou Pharma is a one of the prominent players in the Chinese pharmaceutical formulations market with a strong foothold across multiple therapies. The company have more than 1500 employees across the country and has earned a reputation amongest the Chinese pharmaceutical companies for providing innovative, comprehensive and complete healthcare solutions. At Changzhou pharmaceutical Factory, we have one of the strongest global commercial infrastructures in the industry, with a balanced reach across US, Europe, the Asia Pacific region and emerging markets. Our high quality manufacturing dedicated facilities for Oncology, Non Oncology, Complex Generics, OTC-Products and sterile injectables, scientific excellence and vast supply chain network to improve access to medicine for patients worldwide. The company mainly involves leading pharmaceutical manufacturer a wide range of key Intermediates, Active pharmaceutical ingredients, Finished Formulations meet with global standards, Changzhou Pharmaceutical Factory it covers an area of 300,000㎡ including R&D, dedicated manufacturing, international marketing office. And we maintain an industry -leading pipeline, composed of numerous complex generics and state owned brands. The company annually brings 800 tons of API's and 3000 millions of Finished dosage forms across the Globe.

Our company is engaged in the manufacturing of active pharmaceutical ingredients in Russia and is in the process of finalizing the construction of our facility in Austria dedicated to the production of pharmaceutical drugs. The active pharmaceutical ingredients are derived using the purest fresh water sourced from a reservoir and powered by sustainable electricity from the Novosibirsk hydroelectric power station

PHT International provides comprehensive global solutions for contract research and production to partners in the pharmaceutical, agrochemical, and specialty chemical sectors. Leveraging worldwide sourcing capabilities and cutting-edge process development and cGMP manufacturing, PHT delivers a full range of services in development chemistry, analytical development, advanced intermediate manufacturing, RSM, and API manufacturing at our FDA-inspected facilities. No matter the scope of your project, our team offers more than 28 years of international expertise to ensure your success. GPT Pharmaceuticals Pvt. Ltd was founded in 2009 by a group of professionals with extensive experience in the pharmaceutical industry, specializing in the development and production of Pharmaceutical Formulation Intermediates (PFIs) and various modified release oral dosage forms using advanced Drug Delivery Systems based on polymers. Controlled drug delivery technology is a rapidly advancing area of science that significantly contributes to human healthcare. These delivery systems present numerous advantages over conventional dosage forms, including enhanced efficacy, reduced toxicity, and improved patient compliance. LP Pharmaceutical (Xiamen) Co., Ltd., situated in Xiamen Biomedical Industry Base, formulates and manufactures pharmaceuticals with enhanced delivery properties. Established in 2012 by a team of scientists and business experts with extensive backgrounds in the pharmaceutical industries of the United States and China, the company's proprietary delivery platforms encompass mucosal and oral controlled release. The current therapeutic areas of focus include the central nervous system, digestive system, cardiovascular health, cancer, and AIDS.

CELOGEN PHARMA PVT. LTD. Is a privately owned company, having its head quarters at Navi Mumbai, India. It has been concentrating on the manufacturing and exporting of finished pharmaceuticals. The company strengthened itself with the start of its own Research & Development centre. Celogen conducts its business with a total commitment to it’s Customers and their requirements. We define quality as conformance to our Customer’s needs, both internal and external; and conformance to all quality requirements. At Celogen, Quality is the prime motto. The systems and procedures are well framed to monitor and control process at various stages, so that the final product meets the required standards and specifications.Our personnel involved are qualified and well trained to meet the Quality requirements at each level.

Hebei Jiheng pharmaceutical Co., Ltd. is located at No. 1, Weiwu Street, Hengshui Industrial Park, Hebei Province, China, which is “The head of nine chinese ancient states and the hometown of great confucianism culture”. The company currently branch companies: Shenzhou Jiheng Pharmaceutical Co., Ltd., Jiheng Qingxian Chemical Co., Ltd., Hebei Jiheng Chenhui Pharmaceutical Co., Ltd. and a provincial-level R&D center. Since its establishment in 1996, the company develops intently with great concentration, basis on the mother company Hebei Jiheng Group unique advantages in basic chemicals and talent reserves, have gradually built a antipyretic and analgesic production base, a high-end vitamin production base, a variety of API research and development base, and a high-end preparation exports base in China. Over the years, Jiheng Pharmaceutical obedience to the purpose of "Life with hope together, Jiheng with you "forever , established a complete three-level quality management system, and strictly implemented GMP standards throughout the process. All products passed GMP certification in China, acetaminophen powder and acetaminophen DC passed the State official on-site audit by US FDA , EUGMP, Japan, South Korea and so on, most products has got CEP certifications. The key product acetaminophen production starts from basic chemical raw materials, covered products pharmaceutical intermediates, API, DC, tablets. "Acetaminophen tablet" is the one passed the “national consistency evaluation” . High-end folic acid is directly supplied to well-known pharmaceutical companies, it strives for excellence in quality and fulfills its social responsibility for the future of the motherland.